IBM invests to strengthen research and innovation in Newfoundland and Labrador; a framework to deepen links between the NRC and Canada’s AI research and industry ecosystem, an energy hub to connect modellers and policymakers, and more.
Topic: psychedelics
As Canada eases restrictions on psychedelics, B.C.-based Numinus prepares for clinical trials
Numinus has received Health Canada approval to conduct a clinical trial to test the effects of MDMA, the amphetamine more commonly known as ecstasy, in the treatment of patients suffering from severe post-traumatic stress disorder.
The Short Report – March 10, 2021: Federal funding for applied genomics, investments in plant-based proteins, the death of a renowned Alberta ecologist, and more
The Government of Canada invests $8.6 million towards applied genomics research with another $17.8 million from its partners, Protein Industries Canada funds three plant-based protein projects, the death of renowned Alberta ecologist Dr. David Schindler, and more.